News
Delayed diagnoses seen in children during COVID-19
July 9, 2020
"Pediatricians on the frontline know what to expect with diabetes. Those children who would have come in late prior to the pandemic are now arriving very late."
News
Captopril questioned for diabetes patients in COVID-19 setting
July 2, 2020
Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers, a new study suggests.
![1]()
News
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
June 26, 2020
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early speculation, diuresis may be off the list.
![1]()
News
ED visits for life-threatening conditions declined early in COVID-19 pandemic
June 23, 2020
Visits for MI, stroke, and hypoglycemic crisis dropped 10%-23% over the first 10 weeks.
![1]()
News
Cost of preventable adult hospital stays topped $33 billion in 2017
June 23, 2020
Heart failure, diabetes, and COPD were the most expensive preventable conditions.
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
June 22, 2020
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.
![1]()
News
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
June 16, 2020
In the landmark DAPA-HF trial that enrolled HFrEF patients without diabetes, treatment with dapagliflozin cut incident type 2 diabetes by a relative 32%.
![1]()
News
For COVID-19 plus diabetes, glycemic control tops treatment list
June 15, 2020
Tight glucose control led to better results in patients with diabetes and COVID-19.
News
Half of type 1 diabetes patients with COVID-19 manage at home
June 12, 2020
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to data from the T1D Exchange; mortality was low.
News
10% with diabetes hospitalized for COVID-19 die within a week
June 1, 2020
“Even in diabetes, each increase in BMI is associated with an increase in the risk of intubation and/or death in the 7 days following admission for COVID-19.”
